Background Transcatheter pulmonary valve implantation is approved for the treatment of
dysfunctional right ventricle to pulmonary artery conduits. However, the literature is limited …

Valvular disease remains a major cause of cardiovascular morbidity and mortality
worldwide. 1 Over the past decade, catheter-based interventions in valvular disease have …

Right ventricular outflow tract (RVOT) dysfunction is common following surgical repair of
tetralogy of Fallot and other forms of complex congenital heart disease. This results in …

Background—Transcatheter (percutaneous) pulmonary valve (TPV) replacement has
emerged as a viable therapy for right ventricular outflow tract conduit dysfunction. Little is …

Aims: The aim of this study was to assess the international procedural and short-term to
midterm experience with the new percutaneous Venus P-valve. Methods and results …

Objectives The aim of this study was to demonstrate the safety and functionality of the Alterra
Adaptive Prestent and SAPIEN 3 transcatheter heart valve (THV) in patients with …

Objectives: This study provides the 3-year follow-up results of the COMPASSION
(Congenital Multicenter Trial of Pulmonic Valve Regurgitation Studying the SAPIEN …

Objectives: This study compared the risk of infective endocarditis (IE) after percutaneous
pulmonary valve implantation (PPVI) with the Sapien and Melody valves. Background: The …

Introduction Balloon expandable transcatheter pulmonary valve systems are not applicable
to the large majority of patients with chronic severe pulmonary regurgitation (PR) following …

BackgroundAt present, the exclusion for percutaneous pulmonary valve implantation for free
pulmonary regurgitation after tetralogy of Fallot repair includes an unfavourably large right …